A multicenter, open-label, single-arm phase I/II study to assess the efficacy and safety of WSD0922-FU in patients with EGFR C797Sm+ advanced non-small cell lung cancer (NSCLC) in China (NCT06631989). - KIVIRID

A multicenter, open-label, single-arm phase I/II study to assess the efficacy and safety of WSD0922-FU in patients with EGFR C797Sm+ advanced non-small cell lung cancer (NSCLC) in China (NCT06631989).

Authors: Wei Zhong, Lily Liu, Carina Yu, Zhongyuan Yang

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps8661

Source: Full article

Abstract

TPS8661